RECRUITING

Metabolic Biomarkers in Thoracic Cancers

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to develop a method of using magnetic resonance imaging (MRI) to evaluate lung tumors and other thoracic malignancies. An MRI is a scanning device that uses magnets to make images (pictures) of the body. This study is being done to determine what series of reactions (metabolic pathways) pulmonary nodules use as they burn sugar as fuel for growth. The manner in which the tumor burns (metabolizes) sugar for fuel is being investigated by using a natural, slightly modified, sugar solution (13C-glucose) and studying a small sample of the tumor once it is removed at the time of surgery.

Official Title

Metabolic Biomarkers in Thoracic Cancers

Quick Facts

Study Start:2013-03-20
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02095808

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patients must have known or probable malignant lesions requiring surgical biopsy or excision.
  2. 2. Subjects of all races and ethnic origins over 18 years of age.
  1. 1. Not a surgical candidate.
  2. 2. Poorly controlled diabetes.

Contacts and Locations

Study Contact

Ebele Mbanugo, Ed.D, CCRP
CONTACT
214-648-7097
ebele.mbanugo@utsouthwestern.edu

Principal Investigator

Kemp H Kernstine, MD
PRINCIPAL_INVESTIGATOR
University of Texas Southwestern Medical Center

Study Locations (Sites)

University of Texas Southwestern Medical Center
Dallas, Texas, 75390
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

  • Kemp H Kernstine, MD, PRINCIPAL_INVESTIGATOR, University of Texas Southwestern Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2013-03-20
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2013-03-20
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Lung Cancer